These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12210634)

  • 21. A note on multiple testing procedures in dose finding.
    Bauer P
    Biometrics; 1997 Sep; 53(3):1125-8. PubMed ID: 9333343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High dose selection in general toxicity studies for drug development: A pharmaceutical industry perspective.
    Buckley LA; Dorato MA
    Regul Toxicol Pharmacol; 2009 Aug; 54(3):301-7. PubMed ID: 19477212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A restricted maximum likelihood estimator for truncated height samples.
    A'Hearn B
    Econ Hum Biol; 2004 Mar; 2(1):5-19. PubMed ID: 15463990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonparametric step-down test procedures for finding minimum effective dose.
    Sidik K; Morris RW
    J Biopharm Stat; 1999 May; 9(2):217-40. PubMed ID: 10379690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiplicity adjustment for multiple endpoints in clinical trials with multiple doses of an active treatment.
    Quan H; Luo X; Capizzi T
    Stat Med; 2005 Jul; 24(14):2151-70. PubMed ID: 15909290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dose--response relation for rat spinal cord paralysis analyzed in terms of the effective size of the functional subunit.
    Adamus-Górka M; Mavroidis P; Brahme A; Lind BK
    Phys Med Biol; 2008 Nov; 53(22):6533-47. PubMed ID: 18978440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk/benefit assessments of human diseases: optimum dose for intervention.
    Gaylor DW
    Risk Anal; 2005 Feb; 25(1):161-8. PubMed ID: 15787765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal designs for estimating the most successful dose.
    Zohar S; O'Quigley J
    Stat Med; 2006 Dec; 25(24):4311-20. PubMed ID: 16969893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An adaptive dose-finding design incorporating both toxicity and efficacy.
    Zhang W; Sargent DJ; Mandrekar S
    Stat Med; 2006 Jul; 25(14):2365-83. PubMed ID: 16220478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement error model for misclassified binary responses.
    Roy S; Banerjee T; Maiti T
    Stat Med; 2005 Jan; 24(2):269-83. PubMed ID: 15546132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incorporating extra information in experimental design for bioassay.
    Nordheim EV; Tsiatis A; Shapas TJ
    Biometrics; 1983 Mar; 39(1):87-96. PubMed ID: 6871365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A note on the small sample behavior of logistic regression in a bioassay setting.
    Nottingham QJ; Birch JB
    J Biopharm Stat; 1998 Nov; 8(4):565-76. PubMed ID: 9855034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection.
    Rhomberg LR; Baetcke K; Blancato J; Bus J; Cohen S; Conolly R; Dixit R; Doe J; Ekelman K; Fenner-Crisp P; Harvey P; Hattis D; Jacobs A; Jacobson-Kram D; Lewandowski T; Liteplo R; Pelkonen O; Rice J; Somers D; Turturro A; West W; Olin S
    Crit Rev Toxicol; 2007; 37(9):729-837. PubMed ID: 17957539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thermodynamic basis for expressing dose logarithmically.
    Waddell WJ
    Toxicol Appl Pharmacol; 2008 Apr; 228(2):156-7. PubMed ID: 18191974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating the pi* goodness of fit index for finite mixtures of item response models.
    Revuelta J
    Br J Math Stat Psychol; 2008 May; 61(Pt 1):93-113. PubMed ID: 18482477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A simulation-based comparison of techniques to correct for measurement error in matched case-control studies.
    Guolo A; Brazzale AR
    Stat Med; 2008 Aug; 27(19):3755-75. PubMed ID: 18407572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secondary analysis of case-control data.
    Jiang Y; Scott AJ; Wild CJ
    Stat Med; 2006 Apr; 25(8):1323-39. PubMed ID: 16220494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Confidence intervals for the 50 per cent response dose.
    Faraggi D; Izikson P; Reiser B
    Stat Med; 2003 Jun; 22(12):1977-88. PubMed ID: 12802816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Closure procedures for monotone bi-factorial dose-response designs.
    Hellmich M; Lehmacher W
    Biometrics; 2005 Mar; 61(1):269-76. PubMed ID: 15737103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer.
    Chapet O; Kong FM; Lee JS; Hayman JA; Ten Haken RK
    Radiother Oncol; 2005 Nov; 77(2):176-81. PubMed ID: 16256230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.